3 completed, 2 recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow ARS Pharmaceuticals, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria Placebo, 0.5 mg epinephrine, 1 mg epinephrine - Urticaria Chronic | Phase 2 | Recruiting | ARS Pharmaceuticals, Inc. | 42 | 2025-07-09 | 2026-09-16 |
| Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy Neffy, Adrenaline - Allergic Reactions | Phase 4 | Recruiting | ARS Pharmaceuticals, Inc. | 600 | 2025-05-20 | 2026-04-21 |
| Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares ARS-1 - Urticaria | Phase 2 | Completed | ARS Pharmaceuticals, Inc. | 21 | 2022-07-28 | 2026-04-07 |
| Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma ARS-1 1 mg, Albuterol MDI, Placebo - Asthma | Phase 2 | Completed | ARS Pharmaceuticals, Inc. | 18 | 2022-07-28 | 2026-07-14 |
| Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection ARS-1 with URTI, ARS-1 without URTI - Upper Respiratory Tract Infection | Phase 1 | Completed | ARS Pharmaceuticals, Inc. | 15 | 2021-08-09 | 2022-07-29 |
Asthma (1) · Chronic Urticaria (1) · Hypersensitivity (1) · Respiratory Tract Infections (1) · Urticaria (1)
Epinephrine (3) · Cold Temperature (1)
United States (4) · Australia (1) · Germany (1)
Sarina Tanimoto, MD, PhD (2) · Anthony McGirr, MD (1)